Advertisement
UK markets open in 6 hours 11 minutes
  • NIKKEI 225

    37,942.92
    -517.16 (-1.34%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • CRUDE OIL

    82.72
    -0.09 (-0.11%)
     
  • GOLD FUTURES

    2,329.60
    -8.80 (-0.38%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,849.48
    -1,700.02 (-3.17%)
     
  • CMC Crypto 200

    1,394.65
    -29.45 (-2.07%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Does The Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Share Price Tend To Follow The Market?

Anyone researching Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance theory. Investors may think of volatility as falling into two main categories. The first category is company specific volatility. This can be dealt with by limiting your exposure to any particular stock. The second type is the broader market volatility, which you cannot diversify away, since it arises from macroeconomic factors which directly affects all the stocks on the market.

Some stocks are more sensitive to general market forces than others. Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility). However, Warren Buffett said 'volatility is far from synonymous with risk' in his 2014 letter to investors. So, while useful, beta is not the only metric to consider. To use beta as an investor, you must first understand that the overall market has a beta of one. A stock with a beta greater than one is more sensitive to broader market movements than a stock with a beta of less than one.

View our latest analysis for Tonix Pharmaceuticals Holding

What does TNXP's beta value mean to investors?

Given this level of beta, if the future looks like the past, we could therefore consider it likely that the stock price will experience share price volatility that is roughly similar to the overall market. Share price volatility is well worth considering, but most long term investors consider the history of revenue and earnings growth to be more important. Take a look at how Tonix Pharmaceuticals Holding fares in that regard, below.

NasdaqGM:TNXP Income Statement, January 29th 2020
NasdaqGM:TNXP Income Statement, January 29th 2020

Does TNXP's size influence the expected beta?

Tonix Pharmaceuticals Holding is a rather small company. It has a market capitalisation of US$13m, which means it is probably under the radar of most investors. Companies this small are usually more volatile than the market, whether or not that volatility is correlated. Therefore, it's a bit surprising to see that this stock has a beta value so close to the overall market.

What this means for you:

Since Tonix Pharmaceuticals Holding has a beta close to one, it will probably show a positive return when the market is moving up, based on history. If you're trying to generate better returns than the market, it would be worth thinking about other metrics such as cashflows, dividends and revenue growth might be a more useful guide to the future. In order to fully understand whether TNXP is a good investment for you, we also need to consider important company-specific fundamentals such as Tonix Pharmaceuticals Holding’s financial health and performance track record. I highly recommend you dive deeper by considering the following:

ADVERTISEMENT
  1. Future Outlook: What are well-informed industry analysts predicting for TNXP’s future growth? Take a look at our free research report of analyst consensus for TNXP’s outlook.

  2. Past Track Record: Has TNXP been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of TNXP's historicals for more clarity.

  3. Other Interesting Stocks: It's worth checking to see how TNXP measures up against other companies on valuation. You could start with this free list of prospective options.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.